Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.58
Delayed Data
As of Aug 28
 +0.15 / +2.76%
Today’s Change
4.51
Today|||52-Week Range
6.00
+6.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash104.3M91.2M107.2M91.5M
 
 
 
 
 
Short Term Investment Cash2.7M-13.0M16.0M-15.7M
 
 
 
 
 
Cash & Short Term Investments104.3M91.2M107.2M91.5M
 
 
 
 
 
 
ReceivablesReceivables17.8M23.4M31.9M40.8M
 
 
 
 
 
 
InventoriesInventories8.1M10.5M14.3M18.8M
 
 
 
 
 
 
Current AssetsPrepaid Expenses1.8M1.1M161.0K157.0K
 
 
 
 
 
Other Current Assets0.000.003.4M2.4M
 
 
 
Current Assets132.0M126.3M157.1M153.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross92.5M103.8M96.1M104.2M
 
 
 
 
 
Depreciation-16.0M-23.2M-27.5M-34.4M
 
 
 
 
 
Intangible Assets1.3M1.1M772.0K352.0K
 
 
 
 
 
Other Assets7.0M1.5M14.8M14.5M
 
 
 
 
 
Total Assets215.9M208.8M240.7M238.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.9M2.2M6.1M3.2M
 
 
 
 
 
Short Term Debt4.7M3.3M19.5M50.0M
 
 
 
 
 
Accrued Expenses4.1M7.5M8.7M8.3M
 
 
 
 
 
Other Current Liabilities21.9M16.4M16.6M20.0M
 
 
 
 
 
Other Liabilities40.6M30.2M49.2M79.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt17.3M31.2M32.1M1.8M
 
 
 
 
 
Deferred Taxes-419.1K-445.6K-117.0K-515.0K
 
 
 
 
 
Other Liabilities0.003.2M0.00482.0K
 
 
 
Total Liabilities68.3M75.3M92.3M82.1M
 
 
 
 
 
 
EquityMinority Interest-445.0K-3.9M-2.9M-515.0K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity129.9M117.7M128.7M126.6M
 
 
 
 
 
Total Shareholder Equity129.9M117.7M128.7M126.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding54.8M55.1M55.6M55.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.